[EN] OREXIN 1 RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DES RÉCEPTEURS DE L'OREXINE 1
申请人:HEPTARES THERAPEUTICS LTD
公开号:WO2020120994A1
公开(公告)日:2020-06-18
The disclosures herein relate to novel compounds of formula (I): and salts thereof, wherein W; X; Y; Z; R1; R2; R3 and R4 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of neurological or psychiatric disorders associated with orexin receptors.
本公开涉及公式(I)的新化合物及其盐,其中W;X;Y;Z;R1;R2;R3和R4在此处定义,并其在治疗、预防、改善、控制或减少与促进素受体相关的神经系统或精神障碍的风险中的用途。